Swiss Re earnings calendar and analyst views, shares on SIX in global focus
Published on 06/25/2026 at 14:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSBy Daniel Hoffmann, Chart & Technicals desk. Reviewed prior to publication on 2026-06-25, 14:52.
Swiss Re AG (CH0126881561) heads toward its next reporting dates with a packed earnings calendar and continued attention from global reinsurer peers such as Munich Re and Hannover Rueck. The Zurich-based group is listed on SIX Swiss Exchange, where it is a core name in European insurance indices, according to SIX data and recent market commentary from Reuters and other financial news providers.
Upcoming earnings dates and calendar
Swiss Re sets out its financial timetable each year on its investor relations pages, specifying dates for half-year and full-year results, as well as its annual general meeting and investor day events. The company traditionally reports half-year results in late July or early August and full-year figures in February of the following year, according to its published financial calendar on the Swiss Re investor relations site. Swiss Re investor relations financial calendar
In its latest published timetable, Swiss Re highlights upcoming reporting milestones that will include updates on premiums earned, net income, return on equity and solvency ratios under the Swiss Solvency Test. These dates typically attract coverage from international outlets such as Reuters and Bloomberg, and they often trigger analyst revisions and trading volume spikes on SIX. The group also uses these events to update shareholders on strategic priorities such as capital allocation and growth in reinsurance and corporate solutions.
Analyst consensus and ratings picture
Analysts from major houses including UBS and JPMorgan regularly cover Swiss Re, publishing earnings estimates, rating decisions and price targets that help shape investor expectations. Consensus data from platforms such as MarketScreener and financial portals shows a mix of Buy, Hold and occasional Sell ratings, reflecting differing views on valuation, catastrophe exposure and capital returns. Reuters overview on Swiss Re shares and analyst coverage
Several analysts have pointed to Swiss Re's dividend policy and share buyback framework as key components of the investment case, especially when compared with Munich Re, Hannover Rueck and other European reinsurers. Estimates collected by analyst aggregators indicate expectations for solid earnings in the current and next fiscal year, underpinned by higher reinsurance pricing in property and casualty lines and more disciplined risk selection across natural catastrophe portfolios.
All news and analysis on the Swiss Re AG shares
Follow further updates on Swiss Re AG around earnings dates, analyst estimates and strategy developments across the global reinsurance sector.
How Swiss Re generates its revenue
Swiss Re generates most of its revenue from reinsurance premiums in property and casualty and life and health, supplemented by income from its Corporate Solutions business and investment returns on its asset portfolio. The company underwrites risks worldwide, providing coverage for natural catastrophes, mortality, morbidity and specialty corporate risks, and invests premiums in a diversified portfolio of bonds, equities and alternative assets.
Where the stock trades today
Swiss Re AG trades on SIX Swiss Exchange in Zurich under the ticker SREN. At the latest available close, Swiss Re AG shares changed hands at a recent price level in Swiss francs, as reported by SIX Swiss Exchange and financial data providers.
Swiss Re AG at a glance
- Company: Swiss Re AG
- ISIN: CH0126881561
- WKN: A1H81M
- Ticker: SREN
- Trading venue: SIX Swiss Exchange (Zurich)
- Price (as of 2026-06-25, 14:30): [latest verified price] CHF
- Market cap: [latest verified market capitalization] CHF (as of 2026-06-25)
- Sector / industry: Financials - Reinsurance
- Index membership: SMI / SPI
- Next earnings date: not officially scheduled
This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
